Skip to main content
. 2022 Oct 28;14(21):5300. doi: 10.3390/cancers14215300

Figure 8.

Figure 8

AKT/LSECtin is the downstream of CXCL8 in colon cancer. (A) Western blot was used to detect the expression of p-AKT, AKT and LSECtin in colon cancer cells after pretreated with CXCL8 (100 ng/mL). (B,C) Semi-quantitative analysis results of (A). (D) Western blot was used to detect the expression of p-AKT, AKT and LSECtin in colon cancer cells after pretreated with CXCL8 siRNA. (E,F) Semi-quantitative analysis results of (D). The uncropped blots are shown in Supplementary Material.